, a biotech firm that develops cancer drugs, said Monday that it will move its headquarters from Columbia to New Jersey by the end of September.
The company said it has outgrown its current offices, where all but one of its 18 employees work, and intends to relocate to Lawrenceville, N.J., near Trenton. Officials want to move closer to New York financial markets and join the sizable community of companies and academics working on drug development and commercialization in New Jersey.
The move is contingent on Celsion receiving an economic-development grant from the state of New Jersey, the value of which will depend on how many jobs the company creates there.
Text BUSINESS to 70701 to get Baltimore Sun Business text alerts
We've upgraded our reader commenting system. Learn more
about the new features.
The Baltimore Sun encourages civil dialogue related to our stories; you must register and log-in to our site in order to participate. We reserve the right to remove any user and to delete comments that violate our Terms of Service
. By commenting, you agree to these terms. Please flag inappropriate comments.